Status:
COMPLETED
Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a chronic lung disease. Symptoms include shortness of breath, wheezing, and difficulty exercising. Increasing exercise and physical activity may relieve...
Detailed Description
COPD is a disease in which the lung airways are partly damaged and obstructed, making it difficult to breathe. It is the fourth leading cause of death in the United States. Cigarette smoking is the mo...
Eligibility Criteria
Inclusion
- Expiratory airflow limitation such that FEV1/FVC is less than or equal to 70% and the FEV₁ is greater than or equal to 20% of the predicted amount
- Physical disability, including self-reported difficulty with walking a city block, climbing stairs, lifting and carrying groceries, performing household activities such as cleaning and doing yard work, or getting out of a chair
- Currently lives within a 35-mile radius of Wake Forest University
- Plans to reside in Forsyth County, North Carolina for the entire study
- Willing and able to participate in all aspects of the trial
Exclusion
- Undergoing treatment for cancer
- Severe congestive heart failure
- Stroke
- Peripheral vascular disease
- Coronary artery disease
- Valvular heart disease
- Major psychiatric disease
- Severe anemia
- Liver or kidney disease
- Uncontrolled diabetes or hypertension
- Orthopedic impairment
- Blindness or deafness
- Oxygen desaturation during exercise to less than 90%, at a heart rate less than 50% of predicted maximum for participant's age and without supplemental oxygen
- Inability to exercise due to a physical disability or positive exercise stress test
- Alcohol consumption of greater than two drinks per day in the 2 months prior to study entry
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
318 Patients enrolled
Trial Details
Trial ID
NCT00328484
Start Date
January 1 2002
End Date
July 1 2007
Last Update
July 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University
Winston-Salem, North Carolina, United States, 27109